Ligand-gated Ion Channels

Ligand-gated ion channels remain closed until a ligand, such as a neurotransmitter or ion, binds to the channel's receptor domain. This binding triggers a conformational change that opens the transmembrane pore, allowing ions to pass through. When the ligand dissociates, the channel closes, stopping ion movement. The ligand itself never crosses the membrane.

Ligand-gated ion channels are classified into three subfamilies: Cys-loop channels, which include nicotinic acetylcholine and GABA receptors; Pore-loop channels, including ionotropic glutamate receptors like NMDA and AMPA; and ATP-gated P2X channels, which are cation-permeable channels activated by ATP and regulate muscle contraction and pain mediation.

Ligand-gated ion channels allow neurons to communicate by opening when neurotransmitters bind, permitting ion influx across the membrane. For example, glutamate released in the synaptic cleft binds to glutamate receptors, opening channels and allowing sodium ions to enter, generating an action potential in the target cell.

Excitatory channels like glutamate receptors permit cations such as sodium to enter, depolarizing the membrane and promoting action potentials. Inhibitory channels like GABA receptors permit anions such as chloride to enter, hyperpolarizing the membrane and preventing action potential firing. These excitatory and inhibitory effects of neurotransmitters form the basis of neural signal integration.

Alzheimer's treatments target ligand-gated ion channels through two mechanisms: cholinesterase inhibitors prevent acetylcholine breakdown, prolonging its receptor binding and improving cognition; glutamate receptor antagonists like memantine block calcium influx, preventing nerve damage from excessive excitability while allowing normal synaptic function during physiological glutamate release.

Ligands activating these channels include extracellular messengers like the neurotransmitters acetylcholine and glutamate, as well as intracellular ligands such as cyclic adenosine monophosphate and ions like calcium. Each ligand binds specifically to its corresponding receptor domain, triggering channel opening and ion passage.

Ligand-gated ion channels have two distinct functional regions: a receptor domain where the ligand binds on one side of the membrane, and a transmembrane pore through which only ions pass. The ligand remains bound to its receptor and does not enter the pore, so it cannot cross the membrane. Only the ions flow through the channel.